Postoperative short‐duration nonsteroidal anti‐inflammatory drugs reduce colorectal anastomotic leaks and recurrences – correlation or causation?
暂无分享,去创建一个
R E FE R E N C E S 1. Custers PA, Hupkens BJP, Grotenhuis BA, Kuhlmann KFD, Breukink SO, Beets GL, et al. Selected stage IV rectal cancer patients managed by the watchandwait approach after pelvic radiotherapy: a good alternative to total mesorectal excision surgery? Colorectal Dis. 2022. https://doi.org/10.1111/codi.16034 2. van der Valk MJM, Hilling DE, Bastiaannet E, MeershoekKlein Kranenbarg E, Beets GL, Figueiredo NL, et al. Longterm outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;23(391):2537– 45. 3. Engineer R, Saklani A, D'souza A, Arya S, Kumar S, Ostwal V, et al. Watch and wait approach after neoadjuvant chemoradiotherapy in rectal cancer: initial experience in the Indian subcontinent. Indian J Surg Oncol. 2021;1(12):664– 70. 4. Kanemitsu Y, Shimizu Y, Mizusawa J, Inaba Y, Hamaguchi T, Shida D, et al. Hepatectomy followed by mFOLFOX6 versus hepatectomy alone for liveronly metastatic colorectal cancer (JCOG 0603): a phase II or III randomized controlled trial. J Clin Oncol. 2021;39(34):3789– 99.
[1] S. Chapman,et al. Postoperative nonsteroidal anti‐inflammatory drugs in relation to recurrence, survival and anastomotic leakage after surgery for colorectal cancer , 2022, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[2] D. Cameron,et al. ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours , 2016, Contemporary clinical trials.